134 related articles for article (PubMed ID: 37574011)
1. Management of patients with localized prostate cancer and biochemical recurrence in Spain: A medical survey.
Correa R; Vidal N; Quesada-García A; Marcos R; Muñoz Del Toro J; Muñoz-Rodríguez J
Actas Urol Esp (Engl Ed); 2024 Apr; 48(3):218-227. PubMed ID: 37574011
[TBL] [Abstract][Full Text] [Related]
2. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study - GESCAP group.
Gómez-Veiga F; Rodríguez-Antolín A; Miñana B; Hernández C; Suárez JF; Fernández-Gómez JM; Unda M; Burgos J; Alcaraz A; Rodríguez P; Medina R; Castiñeiras J; Moreno C; Pedrosa E; Cózar JM;
Actas Urol Esp; 2017; 41(6):359-367. PubMed ID: 28285790
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
[TBL] [Abstract][Full Text] [Related]
6. Recurrence rate of localized prostate cancer after radical prostatectomy according to D'amico risk classification in a tertiary referral hospital: association study.
Valdez-Vargas AD; Sánchez-López HM; Badillo-Santoyo MA; Maldonado-Valadez RE; Manzo-Pérez BO; Pérez-Abarca VM; Manzo-Pérez G; Vanzzini-Guerrero MA; Álvarez-Canales JA
Cir Cir; 2021; 89(4):520-527. PubMed ID: 34352860
[TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry.
Garcia-Rodriguez J; Fernandez-Gomez JM; Cozar JM; Miñana B; Gomez-Veiga F; Rodriguez-Antolin A; ;
Actas Urol Esp (Engl Ed); 2020 Apr; 44(3):156-163. PubMed ID: 32113829
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
[TBL] [Abstract][Full Text] [Related]
9.
Deandreis D; Guarneri A; Ceci F; Lillaz B; Bartoncini S; Oderda M; Nicolotti DG; Pilati E; Passera R; Zitella A; Bellò M; Parise R; Carlevato R; Ricardi U; Gontero P
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2804-2815. PubMed ID: 32314028
[TBL] [Abstract][Full Text] [Related]
10. Patterns of practice regarding use of radiation therapy following radical prostatectomy: A survey of Radiation Oncologists and Urologists in Australia and New Zealand.
Lawless A; Kneebone A; Armstrong S; Chander S; Christie D; Finnigan R; Hayden A; Higgs B; Knox M; Sasso G; Sidhom M; Shakespeare TP; Holt T
J Med Imaging Radiat Oncol; 2023 Aug; 67(5):556-563. PubMed ID: 37343171
[TBL] [Abstract][Full Text] [Related]
11. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological predictors of positive
Aydin AM; Haberal B; Artykov M; Bilen CY; Yazici S
Ann Nucl Med; 2019 May; 33(5):326-332. PubMed ID: 30778860
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature.
Sood A; Kishan AU; Evans CP; Feng FY; Morgan TM; Murphy DG; Padhani AR; Pinto P; Van der Poel HG; Tilki D; Briganti A; Abdollah F
Eur Urol Oncol; 2024 Feb; 7(1):27-43. PubMed ID: 37423774
[TBL] [Abstract][Full Text] [Related]
14. Dramatically Polarized Opinion on the Role of Brachytherapy Boost in Management of High-risk Prostate Cancer: A Survey of North American Genitourinary Expert Radiation Oncologists.
McClelland S; Sandler KA; Degnin C; Chen Y; Mitin T
Clin Genitourin Cancer; 2018 Jun; 16(3):e543-e545. PubMed ID: 29452837
[TBL] [Abstract][Full Text] [Related]
15.
Haidar M; Abi-Ghanem AS; Moukaddam H; Jebai ME; Al Zakleet S; Al Rayess S; Akkawi AR; Kassas M; Tamim H; Hajj AE; Estrada-Lobato E; Osman MM; Shamseddine A
Sci Rep; 2022 Nov; 12(1):20500. PubMed ID: 36443430
[TBL] [Abstract][Full Text] [Related]
16. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance and Clinical Impact of
Cerci JJ; Fanti S; Lobato EE; Kunikowska J; Alonso O; Medina S; Novruzov F; Lengana T; Granados C; Kumar R; Rangarajan V; Al-Ibraheem A; Hourani M; Ali NS; Ahmad A; Keidar Z; Küçük O; Elboga U; Bogoni M; Paez D
J Nucl Med; 2022 Feb; 63(2):240-247. PubMed ID: 34215674
[TBL] [Abstract][Full Text] [Related]
18. Importance of
Couñago F; Artigas C; Sancho G; Gómez-Iturriaga A; Gómez-Caamaño A; Maldonado A; Caballero B; López-Campos F; Recio M; Del Cerro E; Henríquez I
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(5):302-314. PubMed ID: 30139594
[TBL] [Abstract][Full Text] [Related]
19. Incidence, prevalence, and treatment patterns in metastatic hormone-sensitive prostate cancer in Spain: ECHOS study.
de Velasco Oria de Rueda G; Plata Bello AC; Landeira M; Mateo M; Anguita P; Pranzo A; Snijder R; Garnham A; Hernández I
Actas Urol Esp (Engl Ed); 2022 Nov; 46(9):557-564. PubMed ID: 36241525
[TBL] [Abstract][Full Text] [Related]
20. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]